Hims and Hers Health Inc vs McKesson Corporation — how do they compare? Hims and Hers Health Inc trades at $30.67 (market cap $7.12B), while McKesson Corporation trades at $896.02 (market cap $105.14B). The key difference: McKesson Corporation is far larger — about 14.8× Hims and Hers Health Inc's market cap, and McKesson Corporation pays a 0.42% dividend while Hims and Hers Health Inc pays none. Which is the better fit depends on your goals.
| HIMS | MCK | |
|---|---|---|
Market Cap | $7.12B | $105.14B |
Sector | Health | Health |
52-Week High | $62.76 | $995.69 |
52-Week Low | $14.52 | $659.01 |
Enterprise Value | $7.82B | $111.67B |
Dividend Yield | — | 0.42% |
Trailing returns across standard periods
Latest headlines on both assets
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →